LNCaP/RFP cells are derived from the human prostate cancer LNCaP cell line by stably integration of a constitutive RFP stably expression construct. LNCaP cells are androgen-sensitive, making them valuable for studying prostate cancer biology and testing potential treatments related to hormone regulation. LNCaP/RFP cells stably express RFP, can be used for in vitro assays and in vivo imaging.
